CorMedix CEO Khoso Baluch's 2021 pay jumps 110% to $2.6M
CorMedix reports 2021 executive compensation
By ExecPay News
Published: August 30, 2022
CorMedix reported fiscal year 2021 executive compensation information on August 30, 2022.
In 2021, seven CorMedix executives received on average a compensation package of $1.6M, a 87% increase compared to previous year.
Average pay of disclosed executives at CorMedix
Khoso Baluch, Chief Executive Officer, received $2.6M in total, which increased by 110% compared to 2020. 65% of Baluch's compensation, or $1.7M, was in option awards. Baluch also received $367K in salary and $531K in other compensation.
Thomas Nusbickel, Former Chief Commercial Officer, received a compensation package of $1.9M. 82% of the compensation package, or $1.5M, was in option awards.
Phoebe Mounts, General Counsel, earned $1.6M in 2021, a 73% increase compared to previous year.
Matthew David, Chief Financial Officer, received $1.4M in 2021, which increases by 30% compared to 2020.
John Armstrong, Former Executive Vice President for Technical Operations, earned $1.3M in 2021, a 70% increase compared to previous year.
Elizabeth Masson-Hurlburt, Executive Vice President and Head of Clinical Operations, received $1.1M in 2021, which increases by 43% compared to 2020.
Elizabeth Hurlburt, Executive Vice President and Head of Clinical Operations, earned $1.1M in 2021.
Related executives
Matthew David
CorMedix
Chief Financial Officer
Phoebe Mounts
CorMedix
General Counsel
Elizabeth Masson-Hurlburt
CorMedix
Executive Vice President and Head of Clinical Operations
Thomas Nusbickel
CorMedix
Former Chief Commercial Officer
Khoso Baluch
CorMedix
Chief Executive Officer
John Armstrong
CorMedix
Former Executive Vice President for Technical Operations
Elizabeth Hurlburt
CorMedix
Executive Vice President and Head of Clinical Operations
You may also like
Source: SEC filing on August 30, 2022.